Enbrel

Type: Product
Name: Enbrel
First reported 16 hours ago - Updated 16 hours ago - 1 reports

Humira Still Key to AbbVie

AbbVie ( NYSE: ABBV     ) markets the planet's top-selling biotechnology drug, and the company's second-quarter results show no signs that Humira's sales pace is slowing.That's good news for AbbVie, but investors are right to wonder whether the company's ... [Published Motley Fool Discussion Boards - 16 hours ago]
First reported Jul 23 2014 - Updated Jul 24 2014 - 1 reports

Novartis announces NEJM publication of two pivotal Phase III secukinumab studies demonstrating statistically significant skin clearance in psoriasis...

Novartis announces NEJM publication of two pivotal Phase III secukinumab studies demonstrating statistically significant skin clearance in psoriasis patientsBy a News Reporter-Staff News Editor at Biotech Week Novartis announced that The New England ... [Published Pharmacy Choice - Jul 23 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Global cell culture market to grow at 10.27% CAGR by 2018

The global cell culture market will grow at a CAGR of 10.27 percent over the period of 2013-2018, predict analysts in a recently released report . The major driver behind this growth is the increased demand for biopharmaceuticals, particularly with growth ... [Published Terrapinn - Jul 23 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 3 reports

Legal thuggery directed at Steve Novella and Science-Based Medicine [Respectful Insolence]

If there’s one characteristic of supporters of dubious medicine, it’s that they hate criticism. Whereas your average skeptic might not like criticism—sensitivity to criticism being a human trait and all—science- and evidence-based criticism tends to ... [Published ScienceBlogs : Combined Feed - Jul 23 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Reverse stroke treatment has family crying tears of joy

FAMILY members of Toowoomba man Joel Shepherd are ecstatic with the results of his first round of reverse stroke therapy.Mr Shepherd, 26, is in the US with his mother Coralie Graham and siblings to undergo perispinal Etanercept treatment.It is hoped the ... [Published Gatton Star - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Global Biosimilar/Follow-on Biologic market expected to reach $36bn by 2020

We’re now mid-way through the long anticipated decade of spectacular ‘patent cliffs’. With some of the pharmaceutical industry’s biggest blockbuster biologics coming off patent, it seems that the market for biosimilar and follow-on biologic products is ... [Published Terrapinn - Jul 22 2014]
Entities: Biologics, Patent, Biocon, Enbrel
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Much interest in stroke treatment

Dave Griffin.A Dunedin man believed to be the first New Zealander toundergo innovative stroke therapy in the United States may havebecome a trailblazer.Brenda Griffin said her phone and social media page had been''red hot'' since the Otago Daily Times ... [Published Otago Daily Times - Jul 21 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Common arthritis drug stopped Alzheimer's in its tracks, researchers say

Share this article:An arthritis drug stopped the deterioration of cognitive functions and activities of daily living capabilities in Alzheimer's patients in a small trial, researchers from the University of Southampton in England recently announced.The ... [Published McKnight's Long Term Care News - Jul 21 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Mom has RA

So my mom was diagnosed with rheumatoid arthritis about 6 years ago or so. She is on enbrel injections, methotrexate, tramadol as needed (pain killer) and i think folic acid.She experiences drenching night sweats, sometimes her one eye gets red and watery/itchy ... [Published HealthBoards - Jul 21 2014]
First reported Jul 18 2014 - Updated Jul 19 2014 - 3 reports

Alzheimer's Progression Slowed Down by Arthritis Drug

With the help of 41 volunteers, researchers with the University of Southampton in the UK have found that a common arthritis drug dubbed Etanercept has the potential to slow down the progression of Alzheimer's.As part of their investigation, the scientists ... [Published Softpedia - Jul 19 2014]
First reported Jul 16 2014 - Updated Jul 17 2014 - 9 reports

Arthritis drug could slow Alzheimer's, study finds

Individuals with Alzheimer's could see the progression of the disease slowed by taking a drug developed for the treatment of arthritis.According to British scientists, Etranercept may prevent the condition from worsening in patients with dementia.Administered ... [Published Noodls - Jul 17 2014]
First reported Jul 09 2014 - Updated Jul 10 2014 - 9 reports

Novartis' Enbrel beater nears a soon-to-crowd psoriasis market

Novartis' ($NVS) in-development drug secukinumab beat out the blockbuster Enbrel in improving symptoms of psoriasis in Phase III, improving the company's odds of success in what promises to be a competitive race among next-generation therapies for the ... [Published FierceBiotech - Jul 10 2014]

Quotes

On top of those threats, Novartis " Sandoz is already developing a biosimilar generic version of Humira it hopes to launch once Humira's patent expires. If Novartis is successful, Humira's sales will likely fall more quickly after it loses exclusivity."
Transparency Market Research published a new report "Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report store...
...accessible in the U S , and we applaud FDA for its progress in making this a reality," Sandoz's injectables chief Mark McCamish said in a statement. "As they've done in Europe and other highly-regulated markets around the world, biosimilars are poised to increase U S patient access to affordable, high-quality biologics, while reducing the financial burden on payers and the overall healthcare system."
"The Board of Protalix and myself are pleased to have Mr. Yanai join our Board as Chairman," stated Mr. Bronfeld. "He brings extensive knowledge and vast experience from his years as CEO at Teva Pharmaceutical Industries and Makhteshim Agan, which will be helpful in further guiding Protalix. We look forward to his leadership as Chairman."

More Content

All (200) | News (161) | Reports (0) | Blogs (35) | Audio/Video (0) | Fact Sheets (3) | Press Releases (1)
sort by: Date | Relevance
Humira Still Key to AbbVie [Published Motley Fool Discussion Boards - 16 hours ago]
Biological Drugs Market: Global Industry Analys... [Published PRWeb - 17 hours ago]
Stock Update: Amgen Inc (NASDAQ:AMGN) – Amgen A... [Published Jutia Group - Jul 25 2014]
FDA opens the door for a Novartis biosimilar of... [Published FierceBiotech - Jul 24 2014]
Protalix BioTherapeutics Names Shlomo Yanai as ... [Published Stock Nod - Jul 24 2014]
Biogen Idec Beats And Raises: Reassessing Its P... [Published Seeking Alpha - Jul 23 2014]
Reports Outline Cancer Therapy Study Findings f... [Published 4 Traders - Jul 23 2014]
Global cell culture market to grow at 10.27% CA... [Published Terrapinn - Jul 23 2014]
Legal thuggery directed at Steve Novella and Sc... [Published ScienceBlogs : Combined Feed - Jul 23 2014]
Another Lawsuit To Suppress Legitimate Criticis... [Published NeuroLogica Blog - Jul 23 2014]
Another Lawsuit To Suppress Legitimate Criticis... [Published Science-Based Medicine - Jul 23 2014]
Novartis announces NEJM publication of two pivo... [Published Pharmacy Choice - Jul 23 2014]
DAILY NEWSFLASH: What's happening in your world... [Published Gympie Times - Jul 22 2014]
Reverse stroke treatment has family crying tear... [Published Gatton Star - Jul 22 2014]
Global Biosimilar/Follow-on Biologic market exp... [Published Terrapinn - Jul 22 2014]
New psoriasis drug shows potential [Published Science Daily - Jul 21 2014]
Much interest in stroke treatment [Published Otago Daily Times - Jul 21 2014]
CEL-SCI Receives $225,000 NIH Research Grant to... [Published Terrapinn - Jul 21 2014]
Common arthritis drug stopped Alzheimer's in it... [Published McKnight's Long Term Care News - Jul 21 2014]
Mom has RA [Published HealthBoards - Jul 21 2014]
Alzheimer's Progression Slowed Down by Arthriti... [Published Softpedia - Jul 19 2014]
Satisfaction of treatment with biologics is hig... [Published British Journal of Dermatology - Jul 18 2014]
Melanoma associated with tumour necrosis factor... [Published British Journal of Dermatology - Jul 18 2014]
Arthritis drug etanercept 'can slow Alzheimer's... [Published Arthritis Research UK - Jul 18 2014]
Arthritis Drug Etanercept Prevents Alzheimer's ... [Published International Business Times India - Jul 18 2014]
Amgen: Grappling With The Reality Of Patent Exp... [Published Seeking Alpha - Jul 18 2014]
Infection Risk and Biologics: Current Update [Published Diabetes Care - Jul 18 2014]
Baxter International (BAX) CEO Discusses Q2 201... [Published Seeking Alpha - Jul 17 2014]
Arthritis drug could slow Alzheimer's, study finds [Published Noodls - Jul 17 2014]
Arthritis Drug Halts Progression of Alzheimer's [Published NewsMax.com - Jul 17 2014]
1 2 3 4 5 6 7
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Legal thuggery directed at Steve Novella and Sc... [Published ScienceBlogs : Combined Feed - Jul 23 2014]
If there’s one characteristic of supporters of dubious medicine, it’s that they hate criticism. Whereas your average skeptic might not like criticism—sensitivity to criticism being a human trait and all—science- and evidence-based criticism tends to ...
Another Lawsuit To Suppress Legitimate Criticis... [Published NeuroLogica Blog - Jul 23 2014]
I suppose it was inevitable. In fact, I’m a bit surprised it took this long. SGU Productions, the Society for Science-based medicine, and I are being sued for an article that I wrote in May of 2013 on Science-Based Medicine . My SBM piece, which was ...
Another Lawsuit To Suppress Legitimate Criticis... [Published Science-Based Medicine - Jul 23 2014]
I suppose it was inevitable. In fact, I’m a bit surprised it took this long. SGU Productions, the Society for Science-based medicine, and I are being sued for an article that I wrote in May of 2013 on Science-Based Medicine . My SBM piece, which was ...
Mom has RA [Published HealthBoards - Jul 21 2014]
So my mom was diagnosed with rheumatoid arthritis about 6 years ago or so. She is on enbrel injections, methotrexate, tramadol as needed (pain killer) and i think folic acid.She experiences drenching night sweats, sometimes her one eye gets red and watery/itchy ...
Coherus Announces Initiation Of Phase 3 Trial O... [Published PR Newswire: Health - Jul 16 2014]
REDWOOD CITY, Calif., July 16, 2014 /PRNewswire/ -- Coherus BioSciences, Inc. announced the start of its Phase 3 trial of CHS-0214, a proposed biosimilar of etanercept  (Enbrel®), in chronic plaque psoriasis (the RaPsOdy trial).  This announcement ...
1 2 3 4 5 6 7

Press Releases

sort by: Date | Relevance
Coherus maakt bekend dat CHS-0214 (Proposed Eta... [Published PR Newswire - Oct 29 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.